Evidence / Pekar et al. · 2020
Blood spermidine and cognitive scores in nursing homes
Selected research. Study type, product relevance and limitations are shown separately.
Editorial study summary
- Study type
- Cross-sectional human biomarker study.
- Product relevance
- Indirect evidence from circulating spermidine, with no supplement intervention.
- Sample or population
- 80 people aged 60–96 in six nursing homes.
- Studied dose
- No assigned dose.
- Duration
- No follow-up period is reported in the abstract.
- Finding
- Blood spermidine concentration correlated with cognitive screening scores.
- Limitations
- Correlation does not validate a diagnostic biomarker or show that supplementation changes cognition.
- Study quality
- Observational biomarker and screening-score comparison. Editorial review was limited to the abstract. No formal risk-of-bias rating was assigned.
- Funding and disclosures
- The PubMed disclosure reports no competing interests. Funding was not verified.
The studies discussed here examine ingredients or other formulations. They do not establish results for this DR.MORGAN finished product.